• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION Back to Search Results
Lot Number VMFA310723
Device Problem Difficult to Advance (2920)
Patient Problems Hematoma (1884); Low Blood Pressure/ Hypotension (1914); Cardiac Tamponade (2226); Pericardial Effusion (3271)
Event Date 12/19/2023
Event Type  Injury  
Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Event Description
It was reported that a trivial pericardial effusion and cardiac tamponade occurred.The procedure was cancelled.During a watchman procedure to treat left atrial appendage closure (laac), a versacross connect kit was selected for use.The patient had an aneurysmal septum, the physician crossed septum in an inferior, mid manner.The versacross dilator and the watchman sheath stuck tenting at septum and then jumped across the left atrium.The patient blood pressure decreases and anesthesia staff increased the blood pressure of the patient throughout the procedure.The left atrium looked compressed and a trivial baseline pericardial effusion was noted.The trivial pericardial effusion at baseline remained the same and no other effusion was noted.The patient was stable, but the physician did continue the procedure due to the atrium changing shape and patient's low blood pressure.Patient went to unit intubated.The procedure was aborted.Computed tomography (ct) will be performed and the patient remains under physician monitoring.It was further reported ct confirmed a small pericardial effusion or hematoma sourced from transseptal puncture to the left atrium wall (resolved, patient went home next day).In (b)(6) 2024 the patient underwent a successful left atrial appendage closure (laac) procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERSACROSS CONNECT LAAC ACCESS SOLUTION
Type of Device
DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION
Manufacturer (Section D)
BAYLIS MEDICAL COMPANY INC.
5959 trans-canada highway
montreal H4T 1 A1
CA  H4T 1A1
Manufacturer (Section G)
BAYLIS MEDICAL COMPANY INC.
5825 explorer drive
mississauga, on L4W 5 P6
CA   L4W 5P6
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key18848799
MDR Text Key337030189
Report Number2124215-2024-12404
Device Sequence Number1
Product Code DRE
UDI-Device Identifier00685447012573
UDI-Public00685447012573
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K220414
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 03/06/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/06/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Lot NumberVMFA310723
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/19/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/15/2023
Is the Device Single Use? Yes
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age69 YR
Patient SexFemale
Patient RaceWhite
-
-